Turkey, Istanbul
Yesim Yildirim
Immunotherapy with Keytruda (Pembrolizumab) is available at Anadolu Medical Center in Gebze, Turkey. One cycle may cost around 160,000 TRY (approximately 3,455 EUR). The clinic follows US standards through its Johns Hopkins Medicine affiliation and holds JCI accreditation.
About the Treatment
Keytruda is an intravenous immunotherapy drug. It helps the immune system fight cancer cells. Each cycle includes the medication and daily inpatient fees for meals and companion stay.
What's Included
- Keytruda medication for one cycle
- Daily inpatient fee covering meals and companion stay
Treatment Process
Patients typically stay 3-5 days for initial diagnostics. Pre-treatment requires PET-CT scans, blood tests, and pathology review. The hospital stay length is determined after evaluation.
Prof. Dr. Eda Şimşek Tanrıkulu leads the oncology team. She specializes in medical oncology and immunotherapy. Her training includes affiliation with Johns Hopkins Hospital.
Clinic Advantages
Anadolu Medical Center is JCI-accredited and ranked among the top 10 hospitals worldwide. It offers a tumor board for treatment planning. Patients can get a free second opinion within 48 hours.
Additional tests like PET-CT or MRI are not included in the base price. Patients pay before each procedure. The treatment protocol adjusts based on individual response.
Contact the clinic to discuss your specific case and treatment plan.